−1.1207USD
−81.66 MUSD
7.16 MUSD
18.94 M
About Acutus Medical, Inc.
Sector
Industry
CEO
Takeo Mukai
Website
Headquarters
Carlsbad
Employees (FY)
233
Founded
2011
ISIN
US0051111096
FIGI
BBG001YSZT60
Acutus Medical, Inc. engages in the development of medical devices and electrophy equipment. It creates electrophysiological mapping systems for the treatment of cardiac arrhythmias, such as atrial fibrillation, and ventricular tachycardia. The company was founded by Randell L. Werneth and Christoph Scharf in 2011 and is headquartered in Carlsbad, CA.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of AFIB is 0.1745 USD — it has increased by 6.53% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Acutus Medical, Inc. stocks are traded under the ticker AFIB.
Acutus Medical, Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
AFIB stock is 15.45% volatile and has beta coefficient of 0.02. Check out the list of the most volatile stocks — is Acutus Medical, Inc. there?
AFIB earnings for the last quarter are −0.52 USD whereas the estimation was −0.62 USD which accounts for 16.20% surprise. Estimated earnings for the next quarter are −0.39 USD. See more details about Acutus Medical, Inc. earnings.
Acutus Medical, Inc. revenue for the last quarter amounts to 5.24 M USD despite the estimated figure of 4.81 M USD. In the next quarter revenue is expected to reach 6.34 M USD.
Yes, you can track Acutus Medical, Inc. financials in yearly and quarterly reports right on TradingView.
AFIB stock has risen by 2.65% compared to the previous week, the month change is a 19.59% fall, over the last year Acutus Medical, Inc. has showed a 75.07% decrease.
AFIB net income for the last quarter is −13.24 M USD, while the quarter before that showed −18.35 M USD of net income which accounts for 27.85% change. Track more Acutus Medical, Inc. financial stats to get the full picture.
Today Acutus Medical, Inc. has the market capitalization of 4.87 M, it has decreased by 8.25% over the last week.
No, AFIB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, AFIB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Acutus Medical, Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 19, 2024, the company has 233.00 employees. See our rating of the largest employees — is Acutus Medical, Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Acutus Medical, Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Acutus Medical, Inc. stock shows the sell signal. See more of Acutus Medical, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Acutus Medical, Inc. EBITDA is −65.93 M USD, and current EBITDA margin is −188.26%. See more stats in Acutus Medical, Inc. financial statements.